Investors Buy High Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the recipient of unusually large options trading on Wednesday. Investors acquired 1,885 put options on the company. This is an increase of approximately 1,101% compared to the typical daily volume of 157 put options.

Evelo Biosciences Price Performance

Shares of NASDAQ:EVLO opened at $0.00 on Thursday. The company has a market cap of $9,490.00, a PE ratio of 0.00 and a beta of 1.51. Evelo Biosciences has a 12-month low of $0.00 and a 12-month high of $0.08.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.